Assessing the visual image quality provided by refractive corrections during keratoconus progression.

Abstract

Purpose: To expand the SyntEyes keratoconus (KTC) model to assess the Visual Image Quality (VIQ) of sphero-cylindrical spectacle and rigid contact lens corrections as keratoconus progresses.

Methods: The previously published SyntEyes KTC eye model to determine best sphero-cylindrical spectacle and rigid contact lens correction in keratoconic eyes was expanded to include the natural progression of keratoconus, thus allowing the assessment of corrected VIQ with disease progression.

Results: As keratoconus progresses, the pattern of visual Strehl ratio (VSX) in correction space for spectacles alters from a typical hourglass into a shell pattern. The former would guide the subjective refraction towards the optimal correction while the latter is relatively insensitive to large dioptric steps. In 15 out of the 20 SyntEyes, the shell pattern eventually produces two foci on different sides of the correction space separated by a clinically significant dioptric difference with a similar, albeit lower VIQ. Wearing the best possible spectacle corrections provided an average gain of up to 3.5 lines of logMAR visual acuity compared to the uncorrected cases, which increased to 5.5 lines for the best rigid contact lens correction. Continuing to wear a spectacle correction as the disease progresses often leads to a VIQ that is almost as bad as the uncorrected case. Continuing to wear a rigid contact lens correction as the disease progresses maintains a relatively high level of VIQ, albeit in the low range for typically well-corrected normal eyes.

Conclusions: The results reflect the clinical experience that subjective refraction is difficult in highly-aberrated keratoconic eyes, the benefit of spectacle correction is short lived and that rigid contact lenses provide better and more stable VIQ with disease progression. Other aspects, such as the presence and behaviour of the second focus in some cases, remain to be confirmed clinically.